AstraZeneca (AZ)

Warning! LobbyFacts is temporarily only showing data up to 19 September 2021. This is because from 20 September, the EU lobby register changed format and the register's secretariat is no longer providing complete and reliable daily data updates which LobbyFacts uses to keep up to date. This temporary problem has not affected LobbyFacts' archive facility, but for today's lobby data, please check the original EU lobby register. We hope the secretariat will remedy this soon, enabling us to launch a new improved and faster version of LobbyFacts.

Tweet this page
How to read and use this data card.

This representative is currently not registered.

Lobbying costs:

WARNING: As this organisation lists one or more EP accredited lobbyists, it is highly improbable that its lobbying costs are lower than €10,000.

WARNING: The lobbying costs declared by this organisation are extraordinarily high and may therefore have been over-declared.

700,000€ - 799,999€

Financial year: 01/01/2018 - 01/12/2018

Lobbyists declared: 2.75 FTE (5)

WARNING: The number of full time equivalent lobbyists declared by this organisation are extraordinarily high and may therefore have been over-declared.


Lobbyists with EP accreditation: 1


Meetings with European Commission: 2

Lobbying costs over the years:


AstraZeneca (AZ)

Registration on EU Transparency Register

42561875992-94 (First registered: 07 Jun 2011)

Goals / Remit

AZ is a global research-based biopharmaceutical company headquartered in the UK. Our skills and resources are focused on discovering, developing and marketing medicines for some of the world’s most serious illnesses, including cancer, diabetes, cardiovacular and respiratory disease. We employ over 59 000 people globally, with 15 000 involved in manufacturing, research and development and commercial activites throughout Europe.


Data Protection Regulation Pharmacetical Industry Strategy Pharmaceutical Incentives (IP) and regulation Health Technology Assessment Seasonal Infuenza Personalised Medicine Sustainable Health Care Innovative Pricing Solutions Research policy & programmes (IMI) Digital Health RWE Generation and Use Trade Policy Brexit


Head office:
1 Francis Crick Avenue Cambridge Biomedical Campus Cambridge Biomedical Campus
Cambridge CB2 0AA
United Kingdom

Tel: 44 2037495000

Belgium office:
AstraZeneca Square de Meeus 37 Square de Meeus 37
Brussels 1000,

Tel: 32 496693430